Yu DH - Search Results

1

Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges.

Yu DH, Xu ZY, Mo S, Yuan L, Cheng XD, Qin JJ. Yu DH, et al. Front Oncol. 2020 Aug 5;10:1389. doi: 10.3389/fonc.2020.01389. eCollection 2020. Front Oncol. 2020. PMID: 32850448 Free PMC article. Review.

2

The role of miRNAs in MDMX-p53 interplay.

Yu D, Xu Z, Cheng X, Qin J. Yu D, et al. J Evid Based Med. 2021 May;14(2):152-160. doi: 10.1111/jebm.12428. Epub 2021 May 14. J Evid Based Med. 2021. PMID: 33988919 Review.

3

Integrative analysis reveals clinically relevant molecular fingerprints in pancreatic cancer.

Song L, Qi S, Hu W, Fang Z, Yu D, Liu T, Wu J, Wu Y, Wu A, Feng L, Xie J, Zhang B, He W, Ning Z, Liu L, Qin JJ, Li S. Song L, et al. Mol Ther Nucleic Acids. 2021 Jul 2;26:11-21. doi: 10.1016/j.omtn.2021.06.015. eCollection 2021 Dec 3. Mol Ther Nucleic Acids. 2021. PMID: 34513290 Free PMC article.

4

Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis.

Qi S, Guan X, Zhang J, Yu D, Yu X, Li Q, Yin W, Cheng XD, Zhang W, Qin JJ. Qi S, et al. Mol Cancer. 2022 Mar 10;21(1):70. doi: 10.1186/s12943-022-01538-4. Mol Cancer. 2022. PMID: 35272681 Free PMC article.

5

Inhibition of STAT3 Signaling Pathway by Terphenyllin Suppresses Growth and Metastasis of Gastric Cancer.

Yu D, Qi S, Guan X, Yu W, Yu X, Cai M, Li Q, Wang W, Zhang W, Qin JJ. Yu D, et al. Front Pharmacol. 2022 Mar 25;13:870367. doi: 10.3389/fphar.2022.870367. eCollection 2022. Front Pharmacol. 2022. PMID: 35401187 Free PMC article.

6

Characterization of a bioactive meroterpenoid isolated from the marine-derived fungus Talaromyces sp.

Hong X, Guan X, Lai Q, Yu D, Chen Z, Fu X, Zhang B, Chen C, Shao Z, Xia J, Qin JJ, Wang W. Hong X, et al. Appl Microbiol Biotechnol. 2022 Apr;106(8):2927-2935. doi: 10.1007/s00253-022-11914-1. Epub 2022 Apr 13. Appl Microbiol Biotechnol. 2022. PMID: 35416486

7

S3I-201 derivative incorporating naphthoquinone unit as effective STAT3 inhibitors: Design, synthesis and anti-gastric cancer evaluation.

Li H, Cai M, Cao F, Yu D, Yang J, Yu W, Chu C, Guan X, Qin JJ, Dong J. Li H, et al. Bioorg Med Chem. 2022 Oct 1;71:116941. doi: 10.1016/j.bmc.2022.116941. Epub 2022 Jul 19. Bioorg Med Chem. 2022. PMID: 35944386

8

Design, synthesis, and biological characterization of a potent STAT3 degrader for the treatment of gastric cancer.

Li H, Wang L, Cao F, Yu D, Yang J, Yu X, Dong J, Qin JJ, Guan X. Li H, et al. Front Pharmacol. 2022 Aug 12;13:944455. doi: 10.3389/fphar.2022.944455. eCollection 2022. Front Pharmacol. 2022. PMID: 36034876 Free PMC article.

9

Dual inhibition of MYC and SLC39A10 by a novel natural product STAT3 inhibitor derived from Chaetomium globosum suppresses tumor growth and metastasis in gastric cancer.

Guan X, Yang J, Wang W, Zhao B, Hu S, Yu D, Yuan L, Shi Y, Xu J, Dong J, Wang J, Cheng XD, Qin JJ. Guan X, et al. Pharmacol Res. 2023 Mar;189:106703. doi: 10.1016/j.phrs.2023.106703. Epub 2023 Feb 17. Pharmacol Res. 2023. PMID: 36804016 Free article.

10

Next-generation small RNA sequencing for microRNAs profiling in the honey bee Apis mellifera.

Chen X, Yu X, Cai Y, Zheng H, Yu D, Liu G, Zhou Q, Hu S, Hu F. Chen X, et al. Insect Mol Biol. 2010 Dec;19(6):799-805. doi: 10.1111/j.1365-2583.2010.01039.x. Epub 2010 Aug 30. Insect Mol Biol. 2010. PMID: 20807255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

370 results

Search Page

Filters